Skip to content

Clinical trials

Phase 1/2 Central Nervous System Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1/2 Country / region: Switzerland Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20131
20172
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeiGene USA, Inc.1
Children's Oncology Group1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
University Hospital Heidelberg1
University Hospital, Geneva1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms6
Glioblastoma3
Brain Neoplasms2
Gliosarcoma2
Neoplasms2
Neoplasms by Site2
Astrocytoma1
Breast Neoplasms1
Bronchial Neoplasms1
Carcinoma, Bronchogenic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.